Marc P. Bonaca, MD, MPH, FAHA, FACC is a cardiologist and vascular medicine specialist who serves as the executive director of CPC Clinical Research and Community Health, as well as Director of Vascular Research and Professor of Medicine at the University of Colorado Anschutz Medical Campus.
Dr. Bonaca earned his medical degree from the University of Connecticut School of Medicine and his MPH at Harvard University. He served as a cardiovascular research fellow with the TIMI Study Group with the Cardiovascular Division of Brigham and Women’s Hospital.
After completion of his training, he joined the faculty at Brigham and Women’s Hospital and Harvard Medical School and became an investigator at the TIMI Study Group. He went on to serve as center director and clinical project principal investigator of the Brigham and Women’s Hospital and Dartmouth Hitchcock Center in the American Heart Association Strategically Focused Research Network in peripheral vascular disease.
Dr. Bonaca’s research focus is on ischemic risk in patients with atherosclerotic vascular disease, risk prediction, and risk modification through the use of pharmacologic and biologic therapies. He has extensive experience in the design and conduct of large, multicenter randomized clinical trials, as well as analyses in registries and real-world datasets. His key areas of interest include patients with peripheral artery disease, polyvascular disease, and diabetes, with a focus on the breadth of risk including ischemic limb outcomes, microvascular complications, and major adverse cardiovascular events. In addition, he is actively investigating the cardiac, vascular, and thrombotic complications associated with novel oncologic therapies.